Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP synthase membrane subunit g pseudogene 1 (ATP5MGP1) is a pseudogene corresponding to the ATP synthase membrane subunit g gene family. Pseudogenes are segments of DNA highly similar to functional genes but are generally non-protein-coding due to mutations or lack of necessary regulatory elements. Like some other pseudogenes, transcripts from ATP5MGP1 may have regulatory roles as non-coding RNAs, primarily by acting as microRNA "sponges" that can modulate the expression of their parent gene or related family members through competition for shared microRNA binding sites. There is currently no evidence establishing ATP5MGP1 as a drug target, receptor, enzyme, transporter, or other therapeutic target class. Thus, it is not considered a direct therapeutic target, and no drugs are known to interact with it or have mechanisms of action associated with it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase membrane subunit g pseudogene 1 (ATP5MGP1).